学会報告


ESMO 2018 Congress

Munich, Germany - 19 Oct - 23 Oct 2018

Phase II clinical trial of first-line eribulin plus trastuzumab for advanced or recurrent HER2-positive breast cancer

Presented by Sakaguchi K, Nakatsukasa K, Taguchi T


Prospective Cohort Study of Real World Chemotherapy Sequence for Metastatic Breast Cancer 

(KBCRN A001: E-SPEC Study)

 

Presented by Katsuhiko Nakatsukasa, Yuichiro Kikawa, et al.